Tag: VC

None Better than One? (A Brief Note on VC in Smaller Hubs)

Biotech venture funding metrics continue at historic highs, highlighting that the robust financing environment in the public markets continues to fuel the private markets as well.  – Bruce Booth, partner Atlas Venture in Data Snapshot: Venture-Backed Biotech Financing Riding High, April 2015 Here in Madison, Wisconsin, you might not know that was true if you

Read More

Could Pharma/Biotech Build an Amazon?

Pharma/Biotech Business Model Innovation When I hear/read about business model innovation in pharma/biotech, the themes generally focus on changes that would improve R&D productivity – moving discoveries from academia to industry more efficiently (some examples of university-related incubators), reproducibility of experiments, venture capital firms creating their own early stage companies, pharma moving R&D innovation external (corporate, biotech and

Read More

Is Biotech Venture Capital Dying?

This post was inspired by the Xconomy story Wisconsin 2013 VC Activity Drops, Shifts to Software from Biotech. To recap, Wisconsin has historically fared very poorly by virtually any measure related to venture capital. And 2013 was ugly form a numbers perspective: VC funding in the state dropped from $95.3M in 2012 to $35.9M. (Here’s

Read More

Early Stage Biotech Investing in Wisconsin: Hot or Not?

In this post, I want to look at funding, particularly via angel investing, of Wisconsin biotech companies over the last few years. On the national scene, Bruce Booth of Atlas Venture suggested in early 2013 that the number of new biotech startups is down and “worth watching closely”. In March, Luke Timmerman of Xconomy wrote

Read More

WI VC Investment: Down (& Out?) in Q3 ’13

The venture capital investment numbers are out for the Q3 2013 (courtesy of NVCA & PwC). I am usually not particularly interested in the quarterly fluctuations but the Wisconsin numbers caught my eye, particularly relative to the national data. National VC Environment The national data across industries puts investment from Q1 to Q3 in 2013 at $20.7B, which compares favorably

Read More

Engineering Capital Flow: Thoughts on Wisconsin & Beyond

Late last month there was a formal announcement of a new $30 million information technology venture capital fund in the state of Wisconsin called 4490 Ventures. The fund is the creation of the State of Wisconsin Investment Board (SWIB) and the Wisconsin Alumni Research Foundation (WARF). The fund will be seed stage, investing $0.5 to

Read More

Madison Tech: Opportunity to Recycle?

An interesting question that came up at the Spring Tech Kickoff last week: what tech success stories have there been in Madison? It is immediately clear that good financial returns for tech investors are important for continued enthusiasm for investment. However, another large factor in success stories is how/whether experienced management is recycled in the

Read More

Biotech Venture Capital – EOY2012

A challenge with data is that the collection methods are critical when you are comparing data from different sources. Over at lifescivc.com, Bruce Booth of Atlas Venture recently referenced 2012 year end numbers for biotech venture capital investment from BioCentury: $5.5 Billion was invested in 2012, up from 2008-2011. Over the last couple of years, I’ve

Read More

Investing in Long Distance Relationships in Wisconsin

In my previous post about 2012 investment capital in Wisconsin, I asserted and supported the following two statements: Wisconsin has a good environment and the capital to seed and grow companies. The state lacks the in-state capital to take companies through the full funding cycle. In this post, I’m moving to the potential takeaways from

Read More

2012 Wisconsin Investment Capital Roundup

The fourth quarter venture capital investment numbers came out, which prompted me to update the biotech investment numbers as well as the Wisconsin VC numbers. As I was looking at the data, I was reminded that for a place with few VC dollars such as Wisconsin (<$100M per year across industries) we need to evaluate

Read More